Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 2
1959 3
1960 2
1961 4
1962 2
1964 1
1965 5
1966 2
1967 6
1968 1
1969 3
1970 3
1971 4
1972 3
1973 1
1974 4
1975 1
1977 2
1978 1
1979 2
1980 3
1981 2
1982 2
1983 2
1984 1
1985 1
1986 1
1987 5
1988 2
1989 3
1990 5
1991 4
1992 5
1993 6
1995 8
1996 7
1997 12
1998 7
1999 4
2000 9
2001 6
2002 8
2003 16
2004 12
2005 16
2006 15
2007 8
2008 26
2009 20
2010 23
2011 21
2012 20
2013 22
2014 17
2015 21
2016 26
2017 26
2018 27
2019 21
2020 30
2021 26
2022 20
2023 22
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

524 results

Results by year

Filters applied: . Clear all
Page 1
A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity.
Meiser P, Knolle MA, Hirschberger A, de Almeida GP, Bayerl F, Lacher S, Pedde AM, Flommersfeld S, Hönninger J, Stark L, Stögbauer F, Anton M, Wirth M, Wohlleber D, Steiger K, Buchholz VR, Wollenberg B, Zielinski CE, Braren R, Rueckert D, Knolle PA, Kaissis G, Böttcher JP. Meiser P, et al. Among authors: anton m. Cancer Cell. 2023 Aug 14;41(8):1498-1515.e10. doi: 10.1016/j.ccell.2023.06.008. Epub 2023 Jul 13. Cancer Cell. 2023. PMID: 37451271 Free article.
Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH.
Dudek M, Pfister D, Donakonda S, Filpe P, Schneider A, Laschinger M, Hartmann D, Hüser N, Meiser P, Bayerl F, Inverso D, Wigger J, Sebode M, Öllinger R, Rad R, Hegenbarth S, Anton M, Guillot A, Bowman A, Heide D, Müller F, Ramadori P, Leone V, Garcia-Caceres C, Gruber T, Seifert G, Kabat AM, Mallm JP, Reider S, Effenberger M, Roth S, Billeter AT, Müller-Stich B, Pearce EJ, Koch-Nolte F, Käser R, Tilg H, Thimme R, Boettler T, Tacke F, Dufour JF, Haller D, Murray PJ, Heeren R, Zehn D, Böttcher JP, Heikenwälder M, Knolle PA. Dudek M, et al. Among authors: anton m. Nature. 2021 Apr;592(7854):444-449. doi: 10.1038/s41586-021-03233-8. Epub 2021 Mar 24. Nature. 2021. PMID: 33762736
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses.
Bayerl F, Meiser P, Donakonda S, Hirschberger A, Lacher SB, Pedde AM, Hermann CD, Elewaut A, Knolle M, Ramsauer L, Rudolph TJ, Grassmann S, Öllinger R, Kirchhammer N, Trefny M, Anton M, Wohlleber D, Höchst B, Zaremba A, Krüger A, Rad R, Obenauf AC, Schadendorf D, Zippelius A, Buchholz VR, Schraml BU, Böttcher JP. Bayerl F, et al. Among authors: anton m. Immunity. 2023 Jun 13;56(6):1341-1358.e11. doi: 10.1016/j.immuni.2023.05.011. Immunity. 2023. PMID: 37315536 Free article.
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
Cardiovascular waveforms - can we extract more from routine signals?
Nandi M, Anton M, Lyle JV. Nandi M, et al. Among authors: anton m. JRSM Cardiovasc Dis. 2022 Sep 7;11:20480040221121438. doi: 10.1177/20480040221121438. eCollection 2022 Jan-Dec. JRSM Cardiovasc Dis. 2022. PMID: 36092374 Free PMC article.
Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries.
ESCP EAGLE Safe Anastomosis Collaborative and NIHR Global Health Research Unit in Surgery. ESCP EAGLE Safe Anastomosis Collaborative and NIHR Global Health Research Unit in Surgery. Br J Surg. 2024 Jan 3;111(1):znad370. doi: 10.1093/bjs/znad370. Br J Surg. 2024. PMID: 38029386 Free PMC article. Clinical Trial.
Mammalian arachidonate 12-lipoxygenases.
Yamamoto S, Takahashi Y, Hada T, Hagiya H, Suzuki H, Reddy GR, Ueda N, Arakawa T, Nakamura M, Matsuda S, Taketani Y, Yoshimoto T, Azekawa T, Morita Y, Ishimura K, Arase S, Glasgow WC, Brash AR, Anton M, Kühn H. Yamamoto S, et al. Among authors: anton m. Adv Exp Med Biol. 1997;400A:127-31. doi: 10.1007/978-1-4615-5325-0_18. Adv Exp Med Biol. 1997. PMID: 9547547 Review. No abstract available.
Liposomal magnetofection.
Mykhaylyk O, Sánchez-Antequera Y, Vlaskou D, Hammerschmid E, Anton M, Zelphati O, Plank C. Mykhaylyk O, et al. Among authors: anton m. Methods Mol Biol. 2010;605:487-525. doi: 10.1007/978-1-60327-360-2_34. Methods Mol Biol. 2010. PMID: 20072903
524 results